| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2001;32:2810.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Radiology and Physics (F.C., D.G.G., A.C.) and Neurosciences (V.G., F.J.K.) Units, Institute of Child Health, University College London, and the Department of Radiology, Great Ormond Street Hospital (W.J., W.K.C.), London, UK.
Correspondence to Dr Fernando Calamante, Radiology and Physics Unit, Institute of Child Health, University College London, 30 Guilford St, London WC1N 1EH, UK. E-mail cfernan{at}ich.ucl.ac.uk
Background and Purpose Ischemic symptoms in patients with moyamoya syndrome (MMS) are usually due to hemodynamically mediated perfusion failure, and identification of abnormal tissue perfusion in these patients is therefore clinically important. Although dynamic susceptibility contrast (DSC) MRI can be used to study tissue perfusion, there are potential technical problems in MMS. This study investigates the scope and limitations of perfusion MRI in the clinical evaluation of such patients.
Methods Thirteen patients with bilateral MMS were studied with the use of structural, diffusion, and perfusion MRI. The DSC MRI data were analyzed both visually and by a quantitative regional analysis, and the relationship between perfusion status and clinical symptoms was investigated.
Results Extensive bilateral DSC MRI abnormalities were observed in all the patients. There was a very heterogeneous distribution of bolus arrival time. The areas of abnormality included the major arterial border zones in all cases, although these usually appeared normal on structural and diffusion MRI. Only the most clinically unstable patients had peak width (defined as time to peak minus bolus arrival time) >5 seconds on the quantitative regional analysis. Several technical limitations of perfusion quantification in MMS are described, as well as the implications of these limitations in patients with other forms of occlusive large-vessel disease.
Conclusions The technical limitations of DSC MRI described in this study are important for the accurate interpretation of perfusion MRI in MMS. Despite these limitations, these preliminary findings suggest that the use of quantitative regional analysis of summary parameters may provide clinically useful information in patients with MMS.
Key Words: cerebral ischemia hypoperfusion moyamoya disease perfusion stenosis
This article has been cited by other articles:
![]() |
T. J. Yun, J.-E. Cheon, D. G. Na, W. S. Kim, I.-O. Kim, K.-H. Chang, K. M. Yeon, I. C. Song, and K.-C. Wang Childhood Moyamoya Disease: Quantitative Evaluation of Perfusion MR Imaging--Correlation with Clinical Outcome after Revascularization Surgery Radiology, April 1, 2009; 251(1): 216 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-J. Rim, H.S. Kim, Y.S. Shin, and S.Y. Kim Which CT Perfusion Parameter Best Reflects Cerebrovascular Reserve?: Correlation of Acetazolamide-Challenged CT Perfusion with Single-Photon Emission CT in Moyamoya Patients AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1658 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.H. Kang, H.S. Kim, and S.Y. Kim Quantitative Cerebrovascular Reserve Measured by Acetazolamide-Challenged Dynamic CT Perfusion in Ischemic Adult Moyamoya Disease: Initial Experience with Angiographic Correlation AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1487 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Neff, P. Horn, P. Schmiedek, C. Duber, and D. J. Dinter 2D cine phase-contrast MRI for volume flow evaluation of the brain-supplying circulation in moyamoya disease. Am. J. Roentgenol., July 1, 2006; 187(1): W107 - W115. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Togao, F. Mihara, T. Yoshiura, A. Tanaka, T. Noguchi, Y. Kuwabara, K. Kaneko, T. Matsushima, and H. Honda Cerebral Hemodynamics in Moyamoya Disease: Correlation between Perfusion-Weighted MR Imaging and Cerebral Angiography. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Nariai, Y Matsushima, S Imae, Y Tanaka, K Ishii, M Senda, and K Ohno Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 663 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manka, F. Traber, J. Gieseke, H. H. Schild, and C. K. Kuhl Three-dimensional Dynamic Susceptibility-weighted Perfusion MR Imaging at 3.0 T: Feasibility and Contrast Agent Dose Radiology, March 1, 2005; 234(3): 869 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kajimoto, H. Moriwaki, N. Yamada, K. Hayashida, J. Kobayashi, K. Miyashita, and H. Naritomi Cerebral Hemodynamic Evaluation Using Perfusion-Weighted Magnetic Resonance Imaging: Comparison With Positron Emission Tomography Values in Chronic Occlusive Carotid Disease Stroke, July 1, 2003; 34(7): 1662 - 1666. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |